| Literature DB >> 29699870 |
Adele Murauer1, Markus Ganzera2.
Abstract
Chinoline alkaloids found in Cinchona bark still play an important role in medicine, for example as antimalarial and antiarrhythmic drugs. For the first time Supercritical Fluid Chromatography has been utilized for their separation. Six respective derivatives (dihydroquinidine, dihydroquinine, quinidine, quinine, cinchonine and cinchonidine) could be resolved in less than 7 min, and three of them quantified in crude plant extracts. The optimum stationary phase showed to be an Acquity UPC2 Torus DEA 1.7 μm column, the mobile phase comprised of CO2, acetonitrile, methanol and diethylamine. Method validation confirmed that the procedure is selective, accurate (recovery rates from 97.2% to 103.7%), precise (intra-day ≤2.2%, inter-day ≤3.0%) and linear (R2 ≥ 0.999); at 275 nm the observed detection limits were always below 2.5 μg/ml. In all of the samples analyzed cinchonine dominated (1.87%-2.30%), followed by quinine and cinchonidine. Their total content ranged from 4.75% to 5.20%. These values are in good agreement with published data, so that due to unmatched speed and environmental friendly character SFC is definitely an excellent alternative for the analysis of these important natural products.Entities:
Keywords: Chinoline alkaloids; Cinchona bark; Cinchona sp.; Quantification; Quinine; Supercritical Fluid Chromatography
Mesh:
Substances:
Year: 2018 PMID: 29699870 PMCID: PMC6193530 DOI: 10.1016/j.chroma.2018.04.038
Source DB: PubMed Journal: J Chromatogr A ISSN: 0021-9673 Impact factor: 4.759
Fig. 1Chemical structure of the assayed Cinchona alkaloids.
Results of method validation.
| Regr. equation | 1 | 2 | 3 | 4 | 5 | 6 |
|---|---|---|---|---|---|---|
| R2 | 0.9998 | 0.9997 | 0.9996 | 0.9992 | 0.9994 | 0.9992 |
| Linear range | 990–30.9 | 990–30.9 | 990–30.9 | 1020−31.9 | 1020−31.9 | 1010−31.6 |
| LOD | 2.3 | 2.4 | 1.5 | 1.4 | 0.6 | 0.9 |
| LOQ | 6.8 | 7.3 | 4.5 | 4.2 | 1.9 | 2.7 |
| intra-day | – | – | – | 1.0 | 1.2 | 2.2 |
| inter-day | – | – | – | 1.9 | 1.8 | 3.0 |
| high spike | 98.5 | 97.8 | 99.5 | 102.3 | 103.3 | 103.7 |
| medium spike | 97.3 | 97.3 | 97.3 | 100.9 | 101.8 | 101.8 |
| low spike | 97.9 | 98.5 | 97.2 | 98.0 | 98.8 | 97.5 |
µg/ml.
Maximum deviation within one day based on peak area in percent.
Deviation over three days based on peak area in percent.
Expressed as recovery rate in percent.
Fig. 2Separation of Cinchona alkaloids by SFC; optimum conditions (A; column: Acquity UPC2 Torus DEA 1.7 µm, 3.0 × 100 mm; mobile phase: CO2 (A) and 0.8% diethylamine in a mixture of 10% acetonitrile and 90% methanol (B); elution: isocratic with 97.7A/2.3B; sample volume: 1 µl; flow rate: 1.8 ml/min; column temperature: 15 °C; ABPR pressure: 150 bar; detection wavelength: 275 nm) and variations thereof: only MeOH and 0.8% DEA as modifier (B), isocratic elution with 2.5% B (C) and separation at 20 °C (D). Peak assignment is according to Fig. 1.
Fig. 3Analysis of sample CC-2017-1 under optimized SFC conditions (see Fig. 2). Peak assignment is according to Fig. 1.
Quantitative results as determined by SFC. Values reflect percent (mg alkaloid/100 mg crude drug), standard deviation are given in parenthesis (n = 3).
| Compound | CC-2017-1 | CC-2017-2 | CC-2017-3 | CC-2017-4 |
|---|---|---|---|---|
| quinine ( | 1.59 (1.22) | 1.89 (0.92) | 1.62 (1.34) | 1.76 (1.34) |
| cinchonine ( | 2.30 (1.23) | 2.16 (0.99) | 1.87 (1.55) | 2.24 (1.22) |
| cinchonidine ( | 0.90 (0.91) | 1.15 (1.47) | 1.26 (1.14) | 1.05 (0.89) |